{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/06/3340189/0/en/Vivani-Medical-Announces-Successful-Dosing-of-All-Participants-in-SLIM-1-a-Phase-1-Trial-Evaluating-NPM-139-a-Miniature-Ultra-Long-Acting-Semaglutide-Implant-for-Chronic-Weight-Man.html", "message": "News view counter 868109 successfully enlarged"}